ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1437

Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Evaluation of K- Ras mutation and Fas tissue expression in common neoplastic and non-neoplastic colonic lesions

International Conference on Pathology

Maha Akl

Posters: J Clin Exp Pathol

DOI: 10.4172/2161-0681.S1.005

Abstract
Introduction: to study role of K-Ras oncogene and Fas receptor protein in colonic lesions among Egyptians and their impact on grades and stages of colorectal carcinoma (CRC). Material and methods: This study enrolled 85 cases: control 10, ulcerative colitis (UC) with and without dysplasia 3 and 7, Crohn?s disease (CD) 10, bilharzial colitis 15 and CRC 40. Immunohistochemical stain for K-Ras and Fas monoclonal antibodies was done. Results: K-Ras was negative in control. UC with and without dysplasia, CD and bilharzial colitis showed positivity for K-Ras relative to CRC (p < 0.05). CRC showed positive correlation between the extent of expression of K-Ras and both the disease grades and the Dukes\? stages of CRC. Seventy percent of control were positive for Fas relative to CRC (p < 0.01). UC with and without dysplasia, CD and bilharzial colitis showed positivity for Fas relative to CRC (p < 0.01). CRC showed a significant inverse correlation between the extent of positive expression of Fas and both disease grades and the Dukes\? stages of CRC. Conclusions: We concluded that CRC showed the most intense K-Ras expression suggesting that it is playing important role in disease progression. K-Ras mutation was not intensely expressed in UC and CD with dysplasia suggesting that it\?s not the only factor involved in progression to neoplasia. CRC express significant lower level of Fas relative to other studied groups. This supports the idea of the ability of neoplastic cells to escape the host immune system by avoiding apoptosis and thus can progress to more advanced stages. Evaluation of K- Ras Mutation and Fas Tissue Expression In Common Neoplastic and Non-Neoplastic Colonic Lesions.
Biography
Top